Support The Moscow Times!

EU Considers Launching Sputnik V Purchase Negotiations – Reuters

Sputnik V is currently undergoing rolling review by the EU’s medicines regulator, the European Medicines Agency (EMA). Kirill Zykov / Moskva News Agency

European Union officials are considering launching negotiations to purchase Russia’s Sputnik V coronavirus vaccine, Reuters reported Monday, citing EU diplomatic and official sources.

The move would mark a major turnaround for Brussels, which has publicly dismissed Russia’s global vaccine supply campaign as a propaganda effort while facing criticism for its own sluggish vaccine rollout. Faced with mounting cases and deaths, EU members Hungary and Slovakia have already purchased doses of Sputnik V in a break with the 27-member bloc.

Requests from four EU members are required to start the purchase talks with Sputnik V’s developers, Reuters reported, citing an unnamed EU official who negotiates with vaccine makers.

Italy is considering using the country’s largest vaccine-producing bioreactor to manufacture Sputnik V, the EU official told Reuters.

Last week, Bloomberg reported that Swiss firm Adienne Pharma & Biotech SA has agreed to produce the Russian vaccine at its production facility in Milan, Italy.

Under its new Prime Minister Mario Draghi, Italy is now pushing fellow EU leaders to consider Sputnik V in an effort to vaccinate more people and expand the bloc’s limited supplies, Reuters reported.

Russian news agencies reported that Rik Daems, president of the Parliamentary Assembly of the Council of Europe (PACE), said Europe is considering obtaining Sputnik V supplies during his Monday meeting with State Duma Speaker Vyacheslav Volodin.  

Sputnik V is currently undergoing rolling review by the EU’s medicines regulator, the European Medicines Agency (EMA).

If the EMA authorizes Sputnik V, the bloc would likely be split between members in favor of cooperating with Russia and those against, an EU diplomat told Reuters.

On Saturday, Sweden’s vaccines coordinator told Swedish media that the country could receive doses of Sputnik V as early as June if the EMA authorizes it.

Sign up for our free weekly newsletter

Our weekly newsletter contains a hand-picked selection of news, features, analysis and more from The Moscow Times. You will receive it in your mailbox every Friday. Never miss the latest news from Russia. Preview
Subscribers agree to the Privacy Policy

A Message from The Moscow Times:

Dear readers,

We are facing unprecedented challenges. Russia's Prosecutor General's Office has designated The Moscow Times as an "undesirable" organization, criminalizing our work and putting our staff at risk of prosecution. This follows our earlier unjust labeling as a "foreign agent."

These actions are direct attempts to silence independent journalism in Russia. The authorities claim our work "discredits the decisions of the Russian leadership." We see things differently: we strive to provide accurate, unbiased reporting on Russia.

We, the journalists of The Moscow Times, refuse to be silenced. But to continue our work, we need your help.

Your support, no matter how small, makes a world of difference. If you can, please support us monthly starting from just $2. It's quick to set up, and every contribution makes a significant impact.

By supporting The Moscow Times, you're defending open, independent journalism in the face of repression. Thank you for standing with us.

Once
Monthly
Annual
Continue
paiment methods
Not ready to support today?
Remind me later.

Read more